002393.SZ
002393.SZ
CNE100000NJ9
LISHENGPHARMA
Loading chart...

Company Profile

Tianjin Lisheng Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of pharmaceutical products in China and internationally. The company offers pharmaceutical, traditional Chinese medicine, and antibiotic products in various forms, such as oral solid dosage forms, soft capsules, sterile preparations, and raw materials primarily for cardiovascular and digestive system applications. Its products also include Shoubishan capsules, Jiayindapamide tablets, Sanyu Zhengtong tablets, Xifuni cefdinir dispersible tablets, and Youhao Maren soft capsules. In addition, the company provides pharmaceutical manufacturing outsourcing services and technology research and development services. Further, it exports its products. The company was founded in 1951 and is headquartered in Tianjin, China. Tianjin Lisheng Pharmaceutical Co.,Ltd. operates as a subsidiary of Tianjin Jinhao Pharmaceutical Co., Ltd.

Related stocks

000078.SZ
000078.SZ • China
NEPTUNUS
1.46 CNY
574.81M USD 1Y -41.8%
600351.SS
600351.SS • China
YABAO PHARMACEUTICAL GROUP CO L
7.07 CNY
732.07M USD 1Y +6.8%
300705.SZ
300705.SZ • China
JIUDIAN
11.23 CNY
840.68M USD 1Y -34%
002038.SZ
002038.SZ • China
SL PHARM
5.76 CNY
885.46M USD 1Y -20.3%
600829.SS
600829.SS • China
HPGC RENMINTONGTAI PHARMACEUTIC
9.52 CNY
826.06M USD 1Y +19.9%
000915.SZ
000915.SZ • China
WIT DYNE
24.22 CNY
849.25M USD 1Y -23.8%
600488.SS
600488.SS • China
TIANJIN TIANYAO PHARMACEUTICAL
6.47 CNY
1.06B USD 1Y +59%
600422.SS
600422.SS • China
KPC PHARMACEUTICALS INC
8.36 CNY
946.93M USD 1Y -40.3%

Key Metrics & Overview

Detailed metrics & financial data of the company

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
34.5% p.a.
Max Drawdown (5Y)
-41.4%
Sharpe Ratio (5Y)
0.05
Beta Factor
-0.08
Size Class
Mid Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (34.5% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -68.6% in the extended horizon.
ende